218 related articles for article (PubMed ID: 35586489)
21. DFNA5 regulates immune cells infiltration and exhaustion.
Hu J; Pei W; Jiang M; Huang Y; Dong F; Jiang Z; Xu Y; Li Z
Cancer Cell Int; 2022 Mar; 22(1):107. PubMed ID: 35248047
[TBL] [Abstract][Full Text] [Related]
22. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma.
Xi G; Cheng R; Liang L; Che N; Wang Y; Zhao N; Liang X; Shao B; Zhao X; Zhang D
Sci Rep; 2023 Apr; 13(1):6957. PubMed ID: 37117215
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
[No Abstract] [Full Text] [Related]
24. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.
Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q
J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232
[TBL] [Abstract][Full Text] [Related]
25. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma.
Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q
J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368
[TBL] [Abstract][Full Text] [Related]
26. Immunological function and prognostic value of lymphoid-specific helicase in liver hepatocellular carcinoma.
Fang Y; Tang W; Zhao D; Zhang X; Li N; Yang Y; Jin L; Li Z; Wei B; Miao Y; Zeng Z; Huang H
Cancer Biomark; 2023; 38(2):225-239. PubMed ID: 37545225
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of MICALL1 and associates with immune infiltration in liver hepatocellular carcinoma patients.
Yang Y; Zhao W; Du J; Wang Y
Cancer Biomark; 2023; 37(3):147-160. PubMed ID: 37248888
[TBL] [Abstract][Full Text] [Related]
28. Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer.
Lan T; Wang Y; Miao J; Guo H; Wang Z; Wang J; Zhang C; Yang P; Zhang Z; Dunmall LC; Wang Y
Front Mol Biosci; 2022; 9():887059. PubMed ID: 35903153
[No Abstract] [Full Text] [Related]
29. FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma.
Hou Y; Li J; Yu A; Deng K; Chen J; Wang Z; Huang L; Ma S; Dai X
Int J Med Sci; 2023; 20(7):918-932. PubMed ID: 37324186
[No Abstract] [Full Text] [Related]
30. Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
Fu S; Gong B; Wang S; Chen Q; Liu Y; Zhuang C; Li Z; Zhang Z; Ma M; Sun T
Int J Gen Med; 2021; 14():8047-8064. PubMed ID: 34795513
[TBL] [Abstract][Full Text] [Related]
31. Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma.
Yu S; Yang Y; Yang H; Peng L; Wu Z; Sun L; Wu Z; Yu X; Yin X
Sci Rep; 2023 May; 13(1):7560. PubMed ID: 37161008
[TBL] [Abstract][Full Text] [Related]
32. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
33. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
34. Prognostic and immunological value of LTB4R in pan-cancer.
Long S; Ji S; Xiao K; Xue P; Zhu S
Math Biosci Eng; 2021 Oct; 18(6):9336-9356. PubMed ID: 34814348
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognosis analysis of
Li H; Li Q; Jing H; Zhao J; Zhang H; Ma X; Wei L; Dai R; Sun W; Suo Z
Front Biosci (Landmark Ed); 2021 Oct; 26(10):707-716. PubMed ID: 34719199
[No Abstract] [Full Text] [Related]
36. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Oncol; 2022; 12():809847. PubMed ID: 35957868
[TBL] [Abstract][Full Text] [Related]
37. DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer.
Deng Z; Xiao M; Du D; Luo N; Liu D; Liu T; Lian D; Peng J
Onco Targets Ther; 2021; 14():2003-2017. PubMed ID: 33776450
[TBL] [Abstract][Full Text] [Related]
38. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis.
He Q; Fan B; Du P; Jin Y
Front Cell Dev Biol; 2022; 10():806989. PubMed ID: 35356272
[No Abstract] [Full Text] [Related]
39. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
Fan X; Wen J; Bao L; Gao F; Li Y; He D
Front Genet; 2021; 12():681809. PubMed ID: 35095994
[TBL] [Abstract][Full Text] [Related]
40. Characterizing
Jin X; Shi H; Li Z; Li H; Ma H; Shi X
J Oncol; 2022; 2022():2717056. PubMed ID: 36213837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]